Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy

Condition:   Alcoholic HepatitisIntervention:   Drug: IDN-6556Sponsors:   Conatus Pharmaceuticals Inc.;   Conatus Pharmaceuticals Inc.;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)Recruiting - verified September 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials